Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jul;7(Suppl 3):S137.
doi: 10.21037/atm.2019.06.06.

Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma

Affiliations
Editorial

Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma

Vincenzo Di Nunno et al. Ann Transl Med. 2019 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

  • Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
    Martínez Chanzá N, Xie W, Asim Bilen M, Dzimitrowicz H, Burkart J, Geynisman DM, Balakrishnan A, Bowman IA, Jain R, Stadler W, Zakharia Y, Narayan V, Beuselinck B, McKay RR, Tripathi A, Pachynski R, Hahn AW, Hsu J, Shah SA, Lam ET, Rose TL, Mega AE, Vogelzang N, Harrison MR, Mortazavi A, Plimack ER, Vaishampayan U, Hammers H, George S, Haas N, Agarwal N, Pal SK, Srinivas S, Carneiro BA, Heng DYC, Bosse D, Choueiri TK, Harshman LC. Martínez Chanzá N, et al. Lancet Oncol. 2019 Apr;20(4):581-590. doi: 10.1016/S1470-2045(18)30907-0. Epub 2019 Feb 28. Lancet Oncol. 2019. PMID: 30827746 Free PMC article.

References

    1. Giles RH, Choueiri TK, Heng DY, et al. Recommendations for the Management of Rare Kidney Cancers. Eur Urol 2017;72:974-83. 10.1016/j.eururo.2017.06.040 - DOI - PubMed
    1. Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. Eur Urol 2016;70:93-105. 10.1016/j.eururo.2016.02.029 - DOI - PubMed
    1. Ciccarese C, Di Nunno V, Montironi R, et al. The role of precision medicine for the treatment of metastatic renal cell carcinoma. Exp Rev Precision Med Drug Development 2016;1:369-77. 10.1080/23808993.2016.1214057 - DOI
    1. Cancer Genome Atlas Research Network , Linehan WM, Spellman PT, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med 2016;374:135-45. 10.1056/NEJMoa1505917 - DOI - PMC - PubMed
    1. Ricketts CJ, De Cubas AA, Fan H, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 2018;23:3698. 10.1016/j.celrep.2018.06.032 - DOI - PubMed